Mischak, Harald,
Urinary proteomics in kidney and cardiovascular disease [electronic resource] / Harald Mischak. - London : Henry Stewart Talks, 2013. - 1 online resource (1 streaming video file (53 min.) : color, sound). - Clinical proteomics, 2056-452X The kidney in health and disease, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Clinical proteomics. Henry Stewart talks. Biomedical & life sciences collection. Kidney in health and disease. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Omics technologies -- Technology platforms: (2DE-MS, LC-MS-MS, CE/MS) -- Clinical proteomics -- Precision as a function of no. of markers -- Human urinary LMW proteome database -- Requirements for biomarker selection -- How to identify valid proteomic biomarkers -- Effect size estimation and the number of samples -- Erroneous biomarkers -- Classification using different sizes of training sets -- Classification errors -- CKD biomarkers -- Biomarker validation -- Pathophysiological suggestions -- Selected urinary peptides and CKD staging -- Multicentric European PRIORITY trial -- Proteomics of coronary artery disease and of diabetic nephropathy.
Access restricted to subscribers.
Mode of access: World Wide Web.
3639 Henry Stewart Talks
Biochemical markers.
Cardiovascular system--Diseases.
Kidneys--Diseases.
Proteomics--Methodology.
Biomarkers.
Cardiovascular Diseases.
Kidney Diseases.
Proteome--analysis.
Proteomics--methods.
Urinary proteomics in kidney and cardiovascular disease [electronic resource] / Harald Mischak. - London : Henry Stewart Talks, 2013. - 1 online resource (1 streaming video file (53 min.) : color, sound). - Clinical proteomics, 2056-452X The kidney in health and disease, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Clinical proteomics. Henry Stewart talks. Biomedical & life sciences collection. Kidney in health and disease. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Omics technologies -- Technology platforms: (2DE-MS, LC-MS-MS, CE/MS) -- Clinical proteomics -- Precision as a function of no. of markers -- Human urinary LMW proteome database -- Requirements for biomarker selection -- How to identify valid proteomic biomarkers -- Effect size estimation and the number of samples -- Erroneous biomarkers -- Classification using different sizes of training sets -- Classification errors -- CKD biomarkers -- Biomarker validation -- Pathophysiological suggestions -- Selected urinary peptides and CKD staging -- Multicentric European PRIORITY trial -- Proteomics of coronary artery disease and of diabetic nephropathy.
Access restricted to subscribers.
Mode of access: World Wide Web.
3639 Henry Stewart Talks
Biochemical markers.
Cardiovascular system--Diseases.
Kidneys--Diseases.
Proteomics--Methodology.
Biomarkers.
Cardiovascular Diseases.
Kidney Diseases.
Proteome--analysis.
Proteomics--methods.